An observational study in Achromatopsia, sponsored by MeiraGTx UK II Ltd. Completed at 1 site in United Kingdom. Open to participants aged 3 Years to 100 Years. Per ClinicalTrials.gov, last updated 2023-06-27.
Sponsored by MeiraGTx UK II Ltd · Observational
In preparation for human clinical trials we intend to undertake a detailed phenotypic study to help to identify patients who may be suitable for therapeutic intervention. In addition, with the recent availability of advanced imaging modalities, further detailed phenotypic investigations will also be valuable in helping to probe the relationship between structure and function and may shed light on disease mechanisms.
62 studies on the registry are indexed under Color Vision Defects; 11 are open to participants now.
This study's enrollment of 85 is below the median of 103 across 15 observational studies indexed under Color Vision Defects.
Browse Color Vision Defects studies →MeiraGTx UK II Ltd is the lead sponsor of 10 studies on the registry; none are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients diagnosed with Achromatopsia
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Diagnostic Test: Ocular assessments
Complete ocular examination, Axial length and corneal curvature, Optical Coherence Tomography, Visual acuity, Contrast sensitivity
Complete ocular examination
Time frame: 5 years
Axial length
Time frame: 5 years
Corneal curvature
Time frame: 5 years
Optical Coherence Tomography
Time frame: 5 years
Visual acuity
Time frame: 5 years
Contrast sensitivity
Time frame: 5 years
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
MeiraGTx UK II Ltd